This inventor holds 1 USPTO granted patent. Top assignees: Hadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Jeremy Zahavy: Innovator in Sphingolipid Research
Introduction
Jeremy Zahavy is a notable inventor based in Modiin, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of synthetic analogs of sphingolipids. His work focuses on creating compounds that have the potential to treat various diseases, showcasing his commitment to advancing medical science.
Latest Patents
Zahavy holds a patent for synthetic analogs of sphingolipids, specifically ceramide analogs indicated as compounds of formula (II). These novel analogs exhibit a significant anti-cancerous effect and are provided as a pharmaceutical composition for treating cell proliferative diseases, neurodegenerative disorders, metabolism-associated conditions, infectious diseases, and immune-related disorders. The invention also includes combined compositions and kits that incorporate these ceramide analogs with additional therapeutic agents.
Career Highlights
Throughout his career, Zahavy has worked with prominent organizations such as Hadasit Medical Research Services and Development Ltd. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Zahavy's notable coworkers include Arie Dagan and Shimon Slavin. Their collaborative efforts have further enhanced the impact of his research and innovations in the medical field.
Conclusion
Jeremy Zahavy's work in developing synthetic analogs of sphingolipids represents a significant advancement in the treatment of various diseases. His innovative approach and dedication to research continue to inspire progress in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile